Titleist Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$531K Hold
4,808
– – 0.03% 279
2026
Q2
$376K Hold
4,808
– – 0.03% 315
2026
Q1
$311K Buy
4,808
+14
+0.3% +$987 0.02% 322
2025
Q4
$323K Hold
4,794
– – 0.03% 295
2025
Q3
$352K Sell
4,794
-60
-1% -$3.99K 0.03% 242
2025
Q2
$253K Hold
4,854
– – 0.03% 278
2025
Q1
$310K Hold
4,854
– – 0.04% 235
2024
Q4
$232K Sell
4,854
-100
-2% -$5.13K 0.03% 282
2024
Q3
$284K Sell
4,954
-40
-0.8% -$2.29K 0.04% 234
2024
Q2
$261K Sell
4,994
-20
-0.4% -$877 0.04% 229
2024
Q1
$204K Buy
+5,014
New +$188K 0.04% 244

Other funds holding HALO

Titleist Asset Management's HALO Position: Q3 2026 in Review

Titleist Asset Management held its Halozyme (HALO) position steady in Q3 2026 at 4,808 shares worth $531K. The position accounts for 0.03% of the portfolio, ranked #279.

Titleist Asset Management first reported a position in HALO in Q1 2024 and has held it in 11 quarters since. 31 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • Titleist Asset Management held 4,808 shares of Halozyme worth $531K as of Q3 2026.
  • Titleist Asset Management left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up 0.03% of Titleist Asset Management's portfolio in Q3 2026, its #279 holding.
  • Titleist Asset Management first reported a position in Halozyme in Q1 2024 and has held it in 11 quarters since.
  • 31 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on Titleist Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.